Wells Fargo & Co (WFC), JPMorgan Chase & Co. (JPM): An Unexpected (but Welcome) Consequence of Rising Mortgage Rates

Page 1 of 2

Wells Fargo & Co (NYSE:WFC)Common sense seems to dictate that rising mortgage rates will hurt the housing market by depressing the demand for purchase-money mortgages. But here’s the thing: The data suggests that the exact opposite may be occurring.

At the end of last week, the nation’s two largest mortgage originators, Wells Fargo & Co (NYSE:WFC) and JPMorgan Chase & Co. (NYSE:JPM), released earnings for the second quarter. Insofar as headline numbers go, both banks had stellar quarters, netting $5.5 billion and $6.5 billion, respectively — Citigroup Inc. (NYSE:C), which reported today, had a similar experience.

But if you dig a bit further, and into their mortgage operations specifically, the story is more nuanced. As expected, the volume of refinance mortgages fell markedly relative to the first quarter. Wells Fargo & Co (NYSE:WFC)’s dropped by 17% and JPMorgan Chase & Co. (NYSE:JPM)’s by 6%.

Unexpectedly, however, both banks reported dramatic sequential upticks in purchase-money mortgage originations. Volume at Wells Fargo & Co (NYSE:WFC) was 46% higher than the first quarter, and JPMorgan Chase & Co. (NYSE:JPM) reported an improvement of 44%.

I say “unexpectedly” because of what we’ve seen happen to mortgage rates since the Federal Reserve first hinted on May 22 that it may begin to taper its support for the economy. Following the announcement, the rate on a 30-year fixed-rate mortgage went from 3.35% at the beginning of May all the way up to 4.51% today.

As the price of a mortgage goes up via the interest rate, conventional economics tells us, the demand for one should go down. But clearly that’s not happening here.

There are at least two explanations for this apparent paradox. The first is that homebuyers are rushing to lock in current rates, which are still exceptionally low on a historical basis, before they head higher.

“I’m afraid we’re going to miss the boat,” an aspiring homeowner recently told CNBC’s Diana Olick. “I feel like we might get priced out of the market in a few months, and just depending on the mortgage payment whether we could afford it if the interest rates go up more.”

The problem with this conclusion is that purchase-money mortgage applications are going down. You can see this in the figure below, which charts the Mortgage Bankers Association’s index for purchase-money and refinance mortgages.

While applications for purchase-money mortgages may not have taken as dramatic a dive as refinance applications, one can’t help but notice a subtle downward slope over the past two months.

It’s for this reason that I prefer the second explanation. Namely, given the precipitous decline in refinance applications, mortgage lenders now have both the motive and the opportunity to pursue purchase-money mortgages.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!